High Prevalence of Hearing Impairment in Primary Congenital Hypothyroidism
- 3 September 2020
- journal article
- research article
- Published by Bioscientifica in European Thyroid Journal
- Vol. 10 (3), 215-221
- https://doi.org/10.1159/000509775
Abstract
Background: An association between hearing impairment (HI) and congenital hypothyroidism (CH) has been reported previously. However, in general, studies were retrospective and had small sample sizes, and the results were variable and inconclusive. The aim of our study was to assess the prevalence of HI among patients with CH and to examine factors potentially predictive of HI including severity of CH, etiology of CH, and timing of treatment initiation. Methods: Audiometry was undertaken prospectively in 66 patients aged 3–21 years diagnosed with primary CH and 49 healthy matched controls. All patients with HI underwent examination by an otolaryngologist, and in patients with sensorineural loss, brainstem evoked response audiometry was performed. A next-generation sequencing (NGS) panel for genes involved in deafness was performed in patients with sensorineural HI to exclude additional genetic etiologies. Results: HI was found in 19 patients (28.7%). Among them, 5 (7.6%) had moderate to severe bilateral sensorineural impairment and 14 (21.2%) had mild conductive HI. Conductive HI was bilateral in 5 of these patients (36%). None of the controls had HI. No specific etiology was found in patients with HI, and no differences were identified in age at diagnosis, age at initiation of levothyroxine (LT4) therapy, gender, or ethnicity between patients with and without HI. A nonsignificant trend toward lower mean screening TT4 levels was found in patients with HI (compared to those without HI) (3.42 vs. 5.34 μg/dL, p = 0.095). No pathogenic variants in genes attributed to HI were identified by NGS in the 5 patients with sensorineural deafness, indicating that HI in these patients was likely attributable to CH rather than other genetic etiologies. Conclusions: Our findings indicate a high prevalence of HI among patients with CH, predominantly of the conductive type. HI was not associated with the etiology of CH or with delayed initiation of LT4 therapy. Audiometry is recommended for children diagnosed with CH and repeat monitoring may be warranted to identify acquired HI and to prevent long-term sequelae of undiagnosed deafness.Keywords
This publication has 35 references indexed in Scilit:
- Minimally Invasive Follicular Thyroid Carcinoma Developed in Dyshormonogenetic Multinodular Goiter Due to Thyroid Peroxidase Gene MutationThyroid®, 2012
- Thyroid Hormone Receptors Control Developmental Maturation of the Middle Ear and the Size of the Ossicular BonesEndocrinology, 2012
- Developmental and Cell-Specific Expression of Thyroid Hormone Transporters in the Mouse CochleaEndocrinology, 2011
- The Importance of Sound for Cognitive Sequencing AbilitiesCurrent Directions in Psychological Science, 2009
- Clinical and genetic characteristics of congenital hypothyroidism due to mutations in the thyroid peroxidase (TPO) gene in IsraelisClinical Endocrinology, 2007
- The prevalence of congenital and early-onset hearing loss in Jordanian and Israeli infantsInternational Journal of Audiology, 2006
- Role of congenital hypothyroidism in hearing loss in childrenThe Journal of Pediatrics, 1994
- Organization of Auditory Callosal Connections in Hypothyroid Adult RatsEuropean Journal of Neuroscience, 1993
- Cochlear synaptogenesis in the hypothyroid ratDevelopmental Brain Research, 1983
- The role of thyroxine in the differentiation of the organ of cortiActa Oto-Laryngologica, 1976